HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
Offering is being led by HeartBeam’s first commercial customer, ClearCardio™, the Company’s executive leadership, board members, and existing investors SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the pricing of its underwritten public offering of 12,500,000 shares of its common … [Read more…]
